全文获取类型
收费全文 | 4426篇 |
免费 | 398篇 |
国内免费 | 77篇 |
专业分类
耳鼻咽喉 | 23篇 |
儿科学 | 240篇 |
妇产科学 | 60篇 |
基础医学 | 656篇 |
口腔科学 | 113篇 |
临床医学 | 476篇 |
内科学 | 809篇 |
皮肤病学 | 101篇 |
神经病学 | 244篇 |
特种医学 | 457篇 |
外科学 | 303篇 |
综合类 | 103篇 |
一般理论 | 5篇 |
预防医学 | 465篇 |
眼科学 | 47篇 |
药学 | 372篇 |
2篇 | |
中国医学 | 1篇 |
肿瘤学 | 424篇 |
出版年
2021年 | 50篇 |
2020年 | 32篇 |
2019年 | 48篇 |
2018年 | 70篇 |
2017年 | 47篇 |
2016年 | 58篇 |
2015年 | 89篇 |
2014年 | 109篇 |
2013年 | 134篇 |
2012年 | 159篇 |
2011年 | 141篇 |
2010年 | 151篇 |
2009年 | 141篇 |
2008年 | 148篇 |
2007年 | 175篇 |
2006年 | 168篇 |
2005年 | 162篇 |
2004年 | 153篇 |
2003年 | 113篇 |
2002年 | 121篇 |
2001年 | 130篇 |
2000年 | 139篇 |
1999年 | 110篇 |
1998年 | 152篇 |
1997年 | 181篇 |
1996年 | 152篇 |
1995年 | 124篇 |
1994年 | 130篇 |
1993年 | 113篇 |
1992年 | 78篇 |
1991年 | 89篇 |
1990年 | 82篇 |
1989年 | 100篇 |
1988年 | 94篇 |
1987年 | 82篇 |
1986年 | 87篇 |
1985年 | 77篇 |
1984年 | 59篇 |
1983年 | 35篇 |
1982年 | 40篇 |
1981年 | 41篇 |
1980年 | 40篇 |
1978年 | 36篇 |
1977年 | 42篇 |
1976年 | 40篇 |
1975年 | 33篇 |
1971年 | 30篇 |
1970年 | 45篇 |
1969年 | 39篇 |
1968年 | 27篇 |
排序方式: 共有4901条查询结果,搜索用时 15 毫秒
1.
JM Martín† L Calduch† C Monteagudo‡ I Molina† D Ramón† V Alonso† E Jordᆠ《Journal of the European Academy of Dermatology and Venereology》2006,20(4):428-431
Cutaneous plasmacytosis is a rare disorder characterized by a benign proliferation of mature plasma cells that appears as multiple dark-brown to purplish skin lesions, often associated with polyclonal hypergammaglobulinaemia. We present the case of a 55-year-old Caucasian man who suffered from a cutaneous plasmacytosis associated with two different carcinomas. Cutaneous plasmacytosis seems to be a reactive process because most cases reported are not associated with any apparent underlying disease. Nevertheless, because few reported cases were associated with malignancies, screening of additional neoplasms would be justified. 相似文献
2.
3.
4.
JM Vilanova J Figueras-Aloy J Roselló G Gómez E Gelpí R Jiménez 《Acta paediatrica (Oslo, Norway : 1992)》1998,87(5):588-592
The aim of this study was to evaluate the cerebral synthesis of eicosanoids in the asphyctic newborn and to investigate the relation between the prostanoid profiles in cerebrospinal fluid (CSF) and the appearance and severity of hypoxic-ischaemic encephalopathy (HIE). Levels of 6-keto-PGF 1-α, TXB2 , PGE2 and PGF2-α in CSF were measured in 40 full term newborns during the first day of life. Thirty of these newborns had birth asphyxia and were divided into three groups: 10 without HIE, 12 with mild HIE and 8 with moderate-severe HIE. They were compared to a control group of 10 non-hypoxic newborns. Determinations of the metabolites in CSF were performed by RIA and expressed as pg/ml (mean ± SD). The CSF TXB2 (thromboxane A2 metabolite) in asphyxiated newborns was always higher than in the control group (28.12 ± 10.6), and related to the severity of HIE ( p = 0:005): without HIE (50.84 ± 16.4; p = 0:02), mild HIE (80.65 ± 12.64; p ± 0:01) and moderate-severe HIE (178.14 ± 20.5; p < 0:01). The CSF 6-keto-PGF 1-α (prostacyclin metabolite) in asphyxiated newborns was always higher than in the control group (80.55 ± 12.56), but indirectly related to the severity of HIE: without HIE (240.95 ± 28.12; p < 0:01), mild HIE (183.65 ± 30.1; p < 0:01) and moderate-severe HIE (140.55 ± 25.12; p < 0:01). In the moderate-severe HIE group, the increase in TXB2 was higher than the rise in 6-keto-PGF 1-α . 相似文献
5.
6.
Long-term precision of 18F-fluoride PET skeletal kinetic studies in the assessment of bone metabolism. 总被引:1,自引:0,他引:1
Michelle L Frost Glen M Blake So-Jin Park-Holohan Gary J R Cook Kathleen M Curran Paul K Marsden Ignac Fogelman 《Journal of nuclear medicine》2008,49(5):700-707
(18)F-Fluoride PET allows noninvasive evaluation of regional bone metabolism and has the potential to become a useful tool for assessing patients with metabolic bone disease and evaluating novel drugs being developed for these diseases. The main PET parameter of interest, termed K(i), reflects regional bone metabolism. The aim of this study was to compare the long-term precision of (18)F-fluoride PET with that of biochemical markers of bone turnover assessed over 6 mo. METHODS: Sixteen postmenopausal women with osteoporosis or significant osteopenia and a mean age of 64 y underwent (18)F-fluoride PET of the lumbar spine and measurements of biochemical markers of bone formation (bone-specific alkaline phosphatase and osteocalcin) and bone resorption (urinary deoxypyridinoline) at baseline and 6 mo later. Four different methods for analyzing the (18)F-fluoride PET data were compared: a 4k 3-compartmental model using nonlinear regression analysis (K(i-4k)), a 3k 3-compartmental model using nonlinear regression analysis (K(i-3k)), Patlak analysis (K(i-PAT)), and standardized uptake values. RESULTS: With the exception of a small but significant decrease in K(i-3k) at 6 mo, there were no significant differences between the baseline and 6-mo values for the PET parameters or biochemical markers. The long-term precision, expressed as the coefficient of variation (with 95% confidence interval in parentheses), was 12.2% (9%-19%), 13.8% (10%-22%), 14.4% (11%-22%), and 26.6% (19%-40%) for K(i-3k), K(i-PAT), mean standardized uptake value, and K(i-4k), respectively. For comparison, the precision of the biochemical markers was 10% (7%-15%), 18% (13%-27%), and 14% (10%-21%) for bone-specific alkaline phosphatase, osteocalcin, and urinary deoxypyridinoline, respectively. Intraclass correlation between the baseline and 6-mo values ranged from 0.44 for K(i-4k) to 0.85 for K(i-3k). No significant correlation was found between the repeated mean standardized uptake value measurements. CONCLUSION: The precision and intraclass correlation observed for K(i-3k) and K(i-PAT) was equivalent to that observed for biochemical markers. This study provided initial data on the long-term precision of (18)F-fluoride PET measured at the lumbar spine, which will aid in the accurate interpretation of changes in regional bone metabolism in response to treatment. 相似文献
7.
8.
9.
10.